Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.656, 2012-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is genetic testing to guide cancer therapy cost effective?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. :
Universal hep A vaccination worth it in Canada?
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :
Which Down's syndrome screening option best in Canada?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 573, 2009-01 ,pp. :
Immunising healthy infants against influenza not worth it in Canada?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 506, 2006-01 ,pp. :
CYP2A6 inhibition beneficial in smoking?
Inpharma, Vol. 1, Iss. 1393, 2003-01 ,pp. :